ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,560Medicare Part D Prescriptions Filled, Including Refills

Rank: 221 out of 690

$420K Total Retail Price of All Prescriptions

Rank: 277 out of 690

394 Patients Receiving at Least One Drug in Part D
85% Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Mississippi
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 394 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

21% of this provider’s 394 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 381 346 67 1 3
LISINOPRIL 332 306 53 2 4
FUROSEMIDE 327 281 57 3 5
AMLODIPINE BESYLATE 317 270 48 4 2
LEVOTHYROXINE SODIUM 288 276 42 5 6
POTASSIUM CHLORIDE 278 244 53 6 10
HYDROCODONE-ACETAMINOPHEN 271 239 82 S3 7 1
METFORMIN HCL 265 239 42 8 8
GABAPENTIN 235 205 46 9 9
WARFARIN SODIUM 221 216* 25 10 22
CITALOPRAM HBR 201 196* 35 11 19
PRAVASTATIN SODIUM 162 144 32 12 11
CLOPIDOGREL 156 142 24 13 16
SIMVASTATIN 154 149* 28 14 7
MELOXICAM 145 140* 30 15 14
ZOLPIDEM TARTRATE 141 125 32 16 24
ATORVASTATIN CALCIUM 135 135 23 17 12
HYDROCHLOROTHIAZIDE 135 130* 29 17 13
GLIMEPIRIDE 130 119 19 19 33
TRAMADOL HCL 123 104 26 20 21
TRIAMTERENE-HCTZ 117 112* 17 21 47
SPIRONOLACTONE 107 95 14 22 63
CARVEDILOL 100 84 15 23 15
CIPROFLOXACIN HCL 96 91* 53 24 50
KLOR-CON 10 96 96 12 24 107
METOPROLOL SUCCINATE 94 94 15 26 17
ATENOLOL 93 82 13 27 31
BENAZEPRIL HCL 90 85* 14 28 68
ALPRAZOLAM 87 82* 16 B 29 20
FLUTICASONE PROPIONATE 86 81* 39 30 46
LEVOFLOXACIN 82 68 57 31 77
CLINDAMYCIN HCL 81 67 46 32 225
ENALAPRIL MALEATE 77 61 11 33 80
DONEPEZIL HCL 76 71* 16 34 27
PRIMIDONE 75 <11 <11 35 287
LOSARTAN POTASSIUM 74 69* 13 36 25
EVISTA 71 <11 <11 37 125
ESCITALOPRAM OXALATE 71 66* 12 37 51
PREDNISONE 71 56 42 37 55
DICLOFENAC POTASSIUM 66 61* 17 40 203
DOXYCYCLINE HYCLATE 63 58* 36 41 131
CELEBREX 63 63 12 41 99
GLIPIZIDE 62 <11 <11 43 78
METOPROLOL TARTRATE 61 <11 <11 44 23
MONTELUKAST SODIUM 61 <11 <11 44 44
DILTIAZEM ER 58 <11 <11 46 137
NAMENDA 58 <11 <11 46 29
SYMBICORT 53 42 18 48 156
VALSARTAN-HYDROCHLOROTHIAZIDE 52 52 12 49 48
BUPROPION XL 51 <11 <11 50 201
CARBIDOPA-LEVODOPA 51 <11 <11 50 133
AZITHROMYCIN 51 46* 43 50 49
FLUCONAZOLE 50 30 28 53 112
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.